Within months of the start of the COVID-19 pandemic, it became clear that the social and physical impacts of the pandemic varied dramatically across demographics: the elderly and African Americans suffered higher mortality rates, while women—and particularly mothers of young children—bore the impact of school and day care closures. Furthermore, the pandemic exacerbated issues in… Read more »
Engagement
IU researchers’ quantifiable soft tissue manipulation device moves closer to helping patients
New technology aims to revolutionize the orthopedic manual therapy industry A new device that would allow physical therapists to monitor the level of pressure they apply to the soft tissue of patients seeking greater mobility and pain relief, developed by Indiana University researchers, is one step closer to the healthcare market. Health Smart Technologies, a… Read more »
Patents awarded to five IU innovations
Five Indiana University researchers have received patents from the U.S. Patent and Trademark Office for cutting-edge technologies and other innovations that they aim to move to market. Below is information about each of the patents. Patent issued to IU innovation that tests cell response to biochemical agents: The U.S. Patent and Trademark Office has issued… Read more »
Patent awarded to IU medical researcher/entrepreneur for wound irrigation device
Every year, 12 million traumatic open wounds are presented at U.S. emergency departments, and it is critical to thoroughly clean these wounds in order to prevent infection. A novel tap water wound irrigation device developed by Dr. Brian Sloan, an associate professor emeritus of clinical emergency medicine at the Indiana University School of Medicine, was… Read more »
IU hosts Midwest consortium seeking to advance materials science innovations
Indiana University recently hosted the Midwest Material Innovation Consortium (MMIC) for a two-day meeting aimed at discussing industry news, trends and opportunities within the material science industry. The event, which took place last month, was organized by IU’s Office of Business Partnerships, together with the IU Innovation and Commercialization Office (ICO) and IU Ventures, IU’s… Read more »
IU ICO interns make an impact in IP protection and faculty-led startups
Izzy Branam, Aishwarya Chaudhari and Crystal Korff are all passionate about bringing IU research to market and protecting intellectual property. Their work at the IU Innovation and Commercialization Office will impact lives across the world. The ICO internship program exposes interns to the day-to-day workings of a university technology transfer office. It provides education and… Read more »
IU researcher develops method for engineering disease resistance in plants
Crop diseases caused by pathogens, viruses and fungi are very costly and can result in significant yield losses for farmers. Roger Innes, Distinguished Professor of biology at Indiana University Bloomington’s College of Arts and Sciences, has developed a method to enhance the immune system of plants to detect harmful pathogens in hopes of preventing these… Read more »
Winners of IU Life Sciences to Healthcare Solutions Pitch Competition announced
Two Indiana University faculty-led teams were selected as winners of the inaugural IU Life Sciences to Healthcare Solutions Pitch Competition, hosted by IU Research and the IU Innovation and Commercialization Office. A future reality portal that enhances addiction recovery won first place, while an instrument that assesses corneal sensation in patients won second place. “This… Read more »
IU expands partnership with NSWC Crane to advance national security innovation
Indiana University and Naval Surface Warfare Center, Crane Division, have announced an expansion of their partnership to effectively leverage IU’s educational and research assets to support the nation’s strategic defense initiatives and advance and accelerate innovative solutions to national security challenges. At a ceremony Monday afternoon, April 24, at IU’s Luddy School of Informatics, Computing… Read more »
IU School of Medicine researcher determines PRMT5 inhibitors can help treat pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth deadliest cancer and has a five-year survival rate of only 10 percent. PDAC, which accounts for more than 90 percent of pancreatic cancer cases, is known to be resistant to most therapeutic agents, and often the diagnosis is late in disease progression as symptoms are difficult to identify…. Read more »